This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

Event Date: 07/29/2019
Location: Washingtron, DC
Subject: Childhood Cancer Data Initiative Symposium - Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, advocacy organizatins and members of the health care services field.

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Lowell J. Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 07/29/2019
Location: Silver Spring, MD
Subject: Contaminated Poppy Seeds
FDA Participant/Group: DAVID GOLDMAN; GRACE KIM; CATHERINE MCDERMOTT; CONRAD CHOINIERE;
Non FDA Participant/Group: Betty Hacala, Gary Underhill, Michelle Underhill, Steve Hacala (Consumers); Lovlean Purewal, Sarah Sorscher (Center for Science in Public Interest);

Event Date: 08/01/2019
Location: Washington, DC
Subject: Food and Beverage Issues of Mutual Interest
FDA Participant/Group: Several FDA officials and staff
Non FDA Participant/Group: Several members of the food and beverage Industry

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 07/31/2019
Location: Mclean, VA
Subject: Duke Clinical Research Institute Conference: Designing and Testing Strategies for Implementing Evidence-Based Medicine
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 07/30/2019
Location: Washington, DC
Subject: National Press Foundation: CBER’s Efforts to Facilitate Vaccine Development
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Event Date: 07/31/2019
Location: Denver, CO
Subject: America’s Blood Centers: FDA’s Approach to Risk and Benefit Considerations for the Blood Supply
FDA Participant/Group: N/A
Non FDA Participant/Group: N/A

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 07/31/2019
Location: Washington, DC
Subject: CVM: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the House Advisory Committee

Event Date: 08/01/2019
Location: Washington, DC
Subject: CVM: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Several members of the American Veterinary Medical Association House of Delegates

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

No Significant Event